This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Pharmaceutical companies run two types of supplychains. There is the commercial supplychain where drugs that have been approved for use on patients are shipped to distributors, drug stores, and hospitals around the world. Then there is a clinical trials supplychain. dollars on drug development.
Safety Stock: Navigating SupplyChain Volatility Through Strategic Inventory Planning Demand volatility represents a critical challenge for supplychain executives today, with safety stock emerging as a key strategic tool to mitigate market uncertainties.
There is growing recognition within pharma that inventory management should be a top priority. Industry insiders are beginning to put increasing focus on improving their inventory management practices, which lag far behind those of other industries. Stock inventory typically ranges between 1 and 8 turns. Pharmaceutical'
If you want to know ahead of time the changes awaiting the pharmaceuticalssupplychain it is useful to extrapolate experiences from the consumer and retail sectors, which were dealing with the same trends and pressures long before pharmaceuticals (for example, the proliferation of distribution channels).
There’s little room for error in most global supplychains, but none for the pharma cold chain. Real-time visibility and tracking are critical to order accuracy, schedule reliability, inventory management and compliance in a high-value, highly regulated industry.
And how can supplychain planning help? In one project, I am interviewing over fifty supplychain leaders on their perceived impact of advanced planning, what makes a good plan, and how effectively they use the technology. I am also writing the new edition of the SupplyChains to Admire.
Pharmacies typically have a vast supplychain network. Managing inventory effectively and carefully is necessary for pharmacy. By enhancing inventory management , a Pharmacy can reduce costs and improve overall operational efficiency. PharmaceuticalInventory software is valuable for pharmaceuticals.
Note: This is part of an ongoing series on the top ten trends affecting the pharmaceuticalsupplychain. Pharmaceuticals manufacturers now realize that integrating upwards of 100 contract manufacturers in different regions into their core ERP would take several years. Number 4: Counterfeiting. The Network Effect'
If you’re a pharmaceutical company, you fear the hit to your business, both headlines and bottom line. Makers of weight loss drugs are looking out a big picture window of patented opportunity right now, but this rosy view is blocked by supplychain challenges. What role can supplychain play in preventing stockouts?
In early April I attended the LogiPharma Europe 2018 conference in Montreux, Switzerland, an event that attracted more than 800 attendees, including practitioners and executives from pharma and medical device industries, along with software vendors and many service providers. Patient-centric networks are reshaping pharmasupplychains.
In my day-to-day work in supplychain management, I find more encounter more opinions than facts. …most discussions are fueled by over-zealous and self-serving marketing programs. Downsizing inventories over the past decade crippled the response.” Days of Inventory Peer Group Across Time Periods. Reflection.
In supplychain management, it is widely accepted that holding enough finished goods inventory to fulfill every order is just too costly. Ipsen, a global bio-pharmaceutical company , disproves that. The post Does Perfect Customer Service Make Sense? appeared first on Logistics Viewpoints.
Today we published a new report, SupplyChains to Admire. The data analyzed to compile the SupplyChains to Admire report came from publicly-available information from balance sheets and income statements. As a result, we report their results along with their pharmaceutical peer group.
Today, we published The SupplyChains to Admire for 2023. Nvidia, Northrup Grumman, PACCAR Inc, PCA (Packaging Corporation of America), ResMed, Rockwell Automation, Ross Stores, Taiwan Semiconductor Manufacturing (TSMC) Company, Tempur-Pedic, TJX, Toro, Toyota, West Pharma, United Tractors, and Urban Outfitters. I admit it.
Supplychain sustainability is a higher priority than ever. In MIT’s State of SupplyChain Sustainability 2021 , 80% of executives surveyed said the pandemic either had no impact on their commitment or increased it. We must plan, source, make, and deliver differently for supplychain sustainability.
“If only I had the money that the company was supposed to save from the multiple ERP and supplychain projects. This year supplychain leaders will celebrate thirty years of progress in supplychain management; but we have not made progress on one of the funamentals: inventory management.
Wikipedia Unleashing the Contrarian Here are my thoughts this morning over coffee: Gartner Top 25: Really A Celebration of SupplyChain Leadership? Designed to lift the profession and celebrate supplychain results, I struggle to find that the methodology supports either objective.
Blockchain in the pharmasupplychain can dramatically affect the success and verifiability of pharmaceuticals. Unlike other industries, pharmaceuticals are subject to intense regulation. Adding Blockchain to the pharmasupplychain could save lives. Returns in the supplychain are not new.
Supplychain resiliency and sustainability are top priorities for CEOs today. To achieve these goals, corporate leadership must focus on two key areas: shift from internally focused supplychains to collaborative supply networks and actively design their supplychains.
Vaccinating the SupplyChain with Andrew Kelley. Andrew Kelley and Joe Lynch discuss vaccinating the supplychain. Andrew is an experienced technology executive and entrepreneur with over 20 years of experience in supplychain, logistics, SaaS, software, and technology-enabled services businesses.
This is a story for the Eds, Franks, and Toms working together in supplychains across the globe. It is also a story for a young supplychain manager attempting to make a difference, but feeling stymied. He felt that inventory was no problem, he would just cut it at the end of each quarter to make the balance sheet goals.
This week, Gartner is hosting their annual supplychain conference. It is now the Gartner SupplyChain Top 25. The research tries to establish “ who did supplychain best ” by looking at a weighted formula of Year-over-Year Growth, Return on Assets (ROA), and Inventory Turns for the Fortune 500 companies.
According to one survey , only 27% of leaders believe that they have the talent needed to meet current supplychain performance requirements. What should supplychain leaders be looking for to close the talent gap? AGCO Logistics Team Accepts Prestigious SupplyChain Award. We need people that are adaptable.
As I was enjoying the holidays, I had an opportunity to reflect on the year past and what the future holds for supplychains. However, organizations will need to be deliberate in designing supplychains with optionality so it does not become cost prohibitive. SupplyChain Design is essential in tackling these.
Earlier this week, I attended the LogiPharma conference, a wonderful event for supplychain professionals working in the pharmaceutical industry. All-in-all, it was a great validation of my point of view about where the pharma industry is with regards to its supplychain challenges, maturity and where it needs to go.
states, obvious disruptions to supplychains and supplychain risk management were a given. Many of the states affected contained key ports and supply destinations, as well as transportation and logistics hubs. The human links of the supplychain were stressed. These ports accounted for 18.3%
The future of supplychain I foresee brings new risks and challenges, along with recognition that doing things the same way will no longer lead to the same success. Just as the saguaro is both nursed by and supports life in its ecosystem, it behooves supplychains to invest in their ecosystems, both suppliers and employees.
Can You Prevent SupplyChain Disruptions in Life Sciences? Supplychain disruptions in the life sciences industry can have serious consequences. While its impossible to eliminate all risks, companies and the industry at large can take proactive steps to minimize disruptions and improve supplychain resilience.
The global supplychain that we know today is built on three assumptions: rational government policy, low variability, and availability of logistics. The impact varies by supplychain sector and value chain. Instead, supplychain leaders need to focus on the minimization of waste, and the alignment of signals.
Megatrends Shaping SupplyChain Innovation. While the COVID-19 pandemic woke up supplychains around the world, the ripple effects continue to disrupt in both size and scope. How are supplychains planning for further disruption and uncertainty? Creating a more resilient supplychain.
Factories for most commodities (other than essential commodities, pharma, medicinal and medical devices, food and groceries) were shutdown globally. Huge demand supply issues breaking the ever-so-fragile supplychain globally. It is now or never for supplychains globally if they do not put their acts together!
Gartner Research analyst Paul Lord has developed a thought-provoking approach (shown in the above diagram) for tailoring supply and inventory tactics to different inventory segments. Traditional ABC inventory models segment inventory into A, B and C categories based on annual consumption value.
Cooper University Health Care Relies Upon Real-time Alerts to Improve Operations Cooper University Health Care, like most companies, struggled with their supplychain during COVID. The company bought a risk solution that provides real-time alerts to potential supply disruptions. We knew exactly what we couldn’t get.”
by Melissa Clow A quick post to let our readers know that we’ll be at the 2015 Pharmaceutical Innovation in Manufacturing Summit (PIMS). What can a lifelong Semiconductor SupplyChain expert have to say about Pharmaceuticals? This year’s event will be held at the Radisson Blu Edwardian Hotel, London, February 10-11, 2015.
I feel that topic of supplychain management is analogous to the downward cycle of the news channels. What Drives SupplyChain Excellence? I analyze supplychain management. The broader the definition of end-to-end strategy and the alignment of supplychain processes drives value.
The hospital built a supplychain organization that is now viewed as stronger than that of its suppliers. The supplier, or healthcare manufacturer (pharmaceutical or medical device) in the healthcare value chain is three times larger than the provider. To focus on the patient, there needs to be a value-chain focus.
When companies want to digitally transform their supplychain capabilities, moving to an integrated business planning process (IBP) is often at the heart of the transformation. GEON Embarks on a Digital Transformation GEON Performance Solutions is embarking on a supplychain transformation. GEON is owned by SK Capital.
Note: this is the final is series of posts that explored the top 10 trends affecting pharmaceuticalsupplychains. . Inventory management a top priority. Second, the most advanced cloud platforms today can enable leading logistics providers to provide a much better infrastructure for the pharmaceutical sector.
by Alexa Cheater Half of organizations playing in the healthcare and life sciences space are feeling the pain of managing overall supplychain costs. At least according to the eighth annual UPS Pain in the Chain Survey. That’s pretty impressive given the increasing complexities in the industry’s supplychain.
At SupplyChain Insights, we have been actively working in our own mine sweeping project. The company was then assigned to one of 37 peer groups based on the SupplyChains to Admire methodology. For this analysis, J&J was assigned to the pharmaceutical industry. Does SupplyChain Planning Drive Value?
If you ask companies if they would like better inventory and global supplychain visibility, you will get an overwhelming answer of, “Yes!” The term supplychain visibility varies by role. Today, I published a new report on building Digital SupplyChains. ” The answer is simple.
Coronavirus continues to impact the world, stunting supplychains and the global economy. Steve Banker has also recently highlighted 20 things to keep in mind as we make contingency plans for the impact […].
When evaluating the 3PL provider in charge of your pharmaceutical distribution warehouse, safety is the name of the game. In this article, we’ve listed several specific questions that you should ask your current or prospective 3PL provider to make sure that your pharmaceutical products are in good hands. tires or coffee).
Today we published a new report, SupplyChains to Admire. The data analyzed to compile the SupplyChains to Admire 2014 report came from publicly-available information from balance sheets and income statements. As a result, we report their results along with their pharmaceutical peer group.
We organize all of the trending information in your field so you don't have to. Join 102,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content